Cannabis and Hemp Industry Investment News
The U.S. cannabis industry generated more than $30 billion in regulated sales in 2025, yet profitability has become harder to predict. According to a ...
Picture the moment a cannabis company’s compliance team gets copied on an email from a banking partner’s risk officer. The subject line says “Question...
As cannabis becomes a globally traded medical commodity, cGMP compliance is reshaping how it is grown, handled, and transported. For operators working...
Cannabis packaging decisions have downstream consequences for compliance, operations, customer perception, and margins. This article offers a practica...
Driven by innovation and convenience, pre-roll sales in 2025 not only had the strongest growth of any major category, topping $3.6 billion in sales an...
For years, the cannabis industry operated in an environment where expansion was the primary signal of success, and investors were excited to get invol...
As the U.S. hemp industry braces for potential federal disruption later this year, a new bipartisan bill aims to give states a way to maintain control...
As federal policymakers move toward restricting hemp-derived cannabinoid products, a new state-level effort in Colorado is taking the opposite approac...
In 2024, Colorado state officials announced a recall affecting 172 stores across the state. Batches of flower and pre-rolled joints from one grower ex...
A cannabis biopharma company is seeking to join the federal lawsuit challenging the Centers for Medicare & Medicaid Services’ (CMS) new hemp and C...
A letter to California’s Assembly Committee on Business and Professions argues a proposed 10mg THC-per-package cap would eliminate 93% of beverage sal...
All roads in cannabis retail lead back to inventory. Retail cannabis operators across the country are being squeezed by razor-thin margins, declining ...
From cultivation to retail, businesses are digging deep to tighten operations and increase margins as the only way to endure another grueling year in ...
WASHINGTON, D.C. – Congressman Troy A. Carter, Sr. (D-LA) and Congressman Guy Reschenthaler (R-PA) have introduced the bipartisan Capital Lending and ...
At the recent Business of Cannabis event in New York, Robert Sciarrone, Chief Revenue Officer at Curaleaf, shared an MSO’s insider view on why he beli...
For many cannabis founders, the exit problem is not finding the right buyer. It is that there are barely any buyers at all. The field is narrow, capit...
It starts with a routine test result. A mid-size cannabis brand discovers that a batch of infused edibles has failed a pesticide screening. Within 48 ...
Missouri has quietly built one of the country’s more successful adult-use cannabis markets since launching recreational sales in 2023. Since legalizat...
While the cannabis industry has made significant strides in incorporating minor cannabinoids into product formulations, a vast number of therapeutic c...
Biotechnology, cannabis medicine, and the rapid advancements in artificial intelligence (AI) and machine learning (ML) are beginning to converge. Hema...
